Talk:Main Page
[+] All Pages
[+] Recent Changes
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
9 June 2025
6 June 2025
[+] Contact Us
- Come discuss your wild ideas with other mad scientists over on our IRC channels! See the Project community guidelines page for more information.
- CyborGhost, the co-founder and currently active content curator, can usually be reached on our IRC server. Or you can just leave a message on their talk page.
- LilianaUmbra, the research librarian, is often on our IRC server. Or you can post a message on her talk page.
- Mabel, the founder, can be sometimes be found on our IRC server. Or alternatively by leaving a message on her talk page.
Research Updates
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy.
A comparison between the ability of cyproterone acetate and spironolactone to lower testosterone levels. Although it shows that cyproterone has a greater effect towards lowering testosterone levels, it ironically notes this metric isn't very meaningful since spironolactone is only an antagonist and does not inhibit steroidogenesis.
The Papers page is a thorough compendium of up-to-date trans-specific research with a high quality of evidence, as well as guides on ways to access them, or find more research.
It is at the heart of all our goals stated in the "About Us" tab below, and one of the more polished articles on the wiki having been curated by our research librarian LilianaUmbra.
Portal Index
Below are all the portals to our content categories, where many of our articles are filed away. Many of these subjects have yet to be filled in, so if a link isn't working that is probably the case.